Veklury is indicated for the treatment of coronavirus disease 2019 (COVID-19) -in adults and pediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment).-adults who do not require supplemental oxygen and who are at increased risk of progressing to severe COVID-19